ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Clinical Trial of High Dose CoQ10 in ALS

ClinicalTrials.gov ID: NCT00243932

Public ClinicalTrials.gov record NCT00243932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00243932
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Columbia University
Other
Enrollment
185 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • coenzyme Q10 Drug

Drug

Eligibility (public fields only)

Age range
21 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2005
Primary completion
Feb 29, 2008
Completion
Feb 29, 2008
Last update posted
May 6, 2024

2005 – 2008

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
17
Facility City State ZIP Site status
University of Arkansas for Medical Sciences, Department of Neurology Little Rock Arkansas 72201
California Pacific Medical Center San Francisco California 94101
University of California at San Francisco San Francisco California 94101
University of Colorado Health Sciences, Dept of Neurology Denver Colorado 80221
Yale University School of Medicine, Department of Neurology New Haven Connecticut 06501
Northwestern University, Department of Neurology, Chicago Illinois 60290
University of Chicago, Department of Neurology Chicago Illinois 60292
University of Kansas Medical Center Kansas City Kansas 64116
University of Kentucky, Dept of Neurology, College of Medicine Lexington Kentucky 40201
Brigham and Women's Hospital , Department of Neurology Boston Massachusetts 02108
Baystate Medical Center, Division of Critical Care Research Springfield Massachusetts 01101
Minneapolis Medical Research Foundation, , Minneapolis Minnesota 55421
Washington University in St. Louis School of Medicine, Department of Neurology St Louis Missouri 63101
Columbia Presbyterian Medical Center, The Neurological Institute New York New York 10032
State University of New York Upstate Medical, Neurology Department Syracuse New York 13201
Cleveland Clinic Foundation Cleveland Ohio 44101
Drexel University, Dept of Neurology Philadelphia Pennsylvania 19113
University of Texas, Health Science Center at San Antonio, Division of Neurology San Antonio Texas 78201
University of Vermont, Neurology Department Burlington Vermont 05401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00243932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2024 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00243932 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →